Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Two-Component Disaggregation of ROE

Medtronic PLC, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = ROA × Financial Leverage
Oct 24, 2025 = ×
Jul 25, 2025 = ×
Apr 25, 2025 = ×
Jan 24, 2025 = ×
Oct 25, 2024 = ×
Jul 26, 2024 = ×
Apr 26, 2024 = ×
Jan 26, 2024 = ×
Oct 27, 2023 = ×
Jul 28, 2023 = ×
Apr 28, 2023 = ×
Jan 27, 2023 = ×
Oct 28, 2022 = ×
Jul 29, 2022 = ×
Apr 29, 2022 = ×
Jan 28, 2022 = ×
Oct 29, 2021 = ×
Jul 30, 2021 = ×
Apr 30, 2021 = ×
Jan 29, 2021 = ×
Oct 30, 2020 = ×
Jul 31, 2020 = ×

Based on: 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).


The analysis of the quarterly financial ratios over the observed periods reveals several notable trends.

Return on Assets (ROA)
The ROA exhibited an initial decline from 4.7% to a low of 2.97% in early 2021, indicating a reduction in efficiency in utilizing assets to generate profit during that time frame. Subsequently, it improved steadily, reaching a peak of approximately 5.79% in mid-2022. After this peak, there was a moderate decline and some fluctuations, with values ranging mostly between 4.1% and 5.2% in the later periods. Overall, ROA demonstrates a recovery and stabilization trend following the early drop.
Financial Leverage
The financial leverage ratio remained relatively stable throughout the entire timeline, fluctuating slightly around the range of 1.7 to 1.9. The ratio started near 1.87, decreased gradually to about 1.71 by mid-2022, and then experienced a mild upward trend toward the end of the period, reaching close to 1.88. This stability suggests consistent use of debt and equity in the company’s capital structure, without significant shifts in financial risk.
Return on Equity (ROE)
ROE trends closely followed the movement observed in ROA but with more pronounced variations due to leverage effects. It declined from 8.77% in mid-2020 to 5.7% at the beginning of 2021, then rose steadily to a high around 9.88% in mid-2022. Following this peak, ROE showed a period of decline and fluctuation between approximately 7.0% and 9.7%, ending near 9.8% at the latest point. The fluctuations indicate variable profitability relative to shareholders’ equity, while the overall upward trend since early 2021 reflects improving returns.

In summary, the company experienced a dip in profitability early in the observed period, particularly evident in ROA and ROE. This was followed by a recovery phase extending into mid-2022. Financial leverage remained stable, supporting consistent equity returns. Profitability metrics have stabilized after initial volatility, suggesting effective asset utilization and equity management in recent quarters.


Three-Component Disaggregation of ROE

Medtronic PLC, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Net Profit Margin × Asset Turnover × Financial Leverage
Oct 24, 2025 = × ×
Jul 25, 2025 = × ×
Apr 25, 2025 = × ×
Jan 24, 2025 = × ×
Oct 25, 2024 = × ×
Jul 26, 2024 = × ×
Apr 26, 2024 = × ×
Jan 26, 2024 = × ×
Oct 27, 2023 = × ×
Jul 28, 2023 = × ×
Apr 28, 2023 = × ×
Jan 27, 2023 = × ×
Oct 28, 2022 = × ×
Jul 29, 2022 = × ×
Apr 29, 2022 = × ×
Jan 28, 2022 = × ×
Oct 29, 2021 = × ×
Jul 30, 2021 = × ×
Apr 30, 2021 = × ×
Jan 29, 2021 = × ×
Oct 30, 2020 = × ×
Jul 31, 2020 = × ×

Based on: 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).


Net Profit Margin
The net profit margin exhibits notable fluctuations over the observed periods, starting at 15.8% and descending to a low point near 10.36%. It subsequently increases again, reaching a peak of 16.75% before experiencing a general downward trend toward the mid-teens, settling around 13.71%. This pattern indicates variations in profitability efficiency, with periods of strong earnings retention interspersed with declines, potentially reflecting changes in cost structure, pricing, or operational effectiveness.
Asset Turnover
The asset turnover ratio demonstrates a gradual and consistent improvement across the timeline, beginning around 0.30 and incrementally rising to approximately 0.38. This steady increase suggests improved efficiency in utilizing assets to generate sales, reflecting progressively better operational performance or asset management strategies that enhance revenue generation capacity relative to asset base.
Financial Leverage
Financial leverage remains relatively stable throughout the periods, fluctuating narrowly between 1.71 and 1.92. This consistency implies a stable approach in the use of debt relative to equity for financing the company’s assets, indicating controlled risk exposure and a potentially conservative capital structure strategy without large swings in leverage.
Return on Equity (ROE)
Return on equity exhibits moderate variability, initially declining from 8.77% to a low near 5.7%, followed by a moderate upward trend stabilizing around 9.79%. ROE movements appear correlated with net profit margin and asset turnover trends, reflecting the combined effects of profitability, asset utilization, and financial leverage on shareholder returns. The recovery and stabilization suggest management efforts to enhance equity returns after periods of reduced profitability.

Five-Component Disaggregation of ROE

Medtronic PLC, decomposition of ROE (quarterly data)

Microsoft Excel
ROE = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Financial Leverage
Oct 24, 2025 = × × × ×
Jul 25, 2025 = × × × ×
Apr 25, 2025 = × × × ×
Jan 24, 2025 = × × × ×
Oct 25, 2024 = × × × ×
Jul 26, 2024 = × × × ×
Apr 26, 2024 = × × × ×
Jan 26, 2024 = × × × ×
Oct 27, 2023 = × × × ×
Jul 28, 2023 = × × × ×
Apr 28, 2023 = × × × ×
Jan 27, 2023 = × × × ×
Oct 28, 2022 = × × × ×
Jul 29, 2022 = × × × ×
Apr 29, 2022 = × × × ×
Jan 28, 2022 = × × × ×
Oct 29, 2021 = × × × ×
Jul 30, 2021 = × × × ×
Apr 30, 2021 = × × × ×
Jan 29, 2021 = × × × ×
Oct 30, 2020 = × × × ×
Jul 31, 2020 = × × × ×

Based on: 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).


Tax Burden
The tax burden ratio exhibits a general declining trend from July 2020, starting above 1.2, decreasing below 1.0 by early 2021, and stabilizing around the 0.7 to 0.8 range from 2022 onwards. This indicates a reduction in the effective tax impact over time, improving net profitability margins after tax expenses.
Interest Burden
The interest burden ratio initially declines from 0.85 in mid-2020 to about 0.73 in early 2021, but subsequently recovers and remains relatively stable near 0.9 through the following years. The consistency in this ratio after the initial dip suggests stable interest costs relative to earnings before interest and taxes during the majority of the periods observed.
EBIT Margin
The EBIT margin shows a modest initial decline from 15.43% in mid-2020 down to approximately 12.42% in early 2021. Following this, there is a marked and sustained increase, with margins rising steadily to surpass 19% by early 2023. After peaking, the margin slightly fluctuates but remains within the 17% to 19% range through 2025, indicating enhanced operational efficiency and profitability.
Asset Turnover
The asset turnover ratio displays a gradual upward movement from 0.30 in July 2020 to around 0.38 by late 2025. This improvement reflects increasing efficiency in generating sales from asset investments, suggesting better asset utilization and operational productivity over time.
Financial Leverage
Financial leverage experiences minor fluctuations with a slight downward trend from approximately 1.87 in mid-2020 to a low near 1.71 by mid-2022. Subsequently, leverage inches upward again, reaching about 1.9 nearing late 2025. These changes indicate moderate variability in the use of debt relative to equity but no dramatic shifts in capital structure.
Return on Equity (ROE)
Return on equity declines from 8.77% in mid-2020 to a low near 5.7% in early 2021, mirroring the trend in EBIT margin and tax burden during that period. ROE then shows a recovery and a steady increase, generally fluctuating between 7% and 9.8% from 2022 through 2025. This reflects an improving ability to generate shareholder returns, supported by better margins and increased asset efficiency, despite relatively stable financial leverage.

Two-Component Disaggregation of ROA

Medtronic PLC, decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Net Profit Margin × Asset Turnover
Oct 24, 2025 = ×
Jul 25, 2025 = ×
Apr 25, 2025 = ×
Jan 24, 2025 = ×
Oct 25, 2024 = ×
Jul 26, 2024 = ×
Apr 26, 2024 = ×
Jan 26, 2024 = ×
Oct 27, 2023 = ×
Jul 28, 2023 = ×
Apr 28, 2023 = ×
Jan 27, 2023 = ×
Oct 28, 2022 = ×
Jul 29, 2022 = ×
Apr 29, 2022 = ×
Jan 28, 2022 = ×
Oct 29, 2021 = ×
Jul 30, 2021 = ×
Apr 30, 2021 = ×
Jan 29, 2021 = ×
Oct 30, 2020 = ×
Jul 31, 2020 = ×

Based on: 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).


The analysis of the financial data reveals several key trends in profitability and operational efficiency indicators over the multiple quarters observed.

Net Profit Margin
The net profit margin exhibited a fluctuating pattern within a range predominantly between approximately 10% and 16%. Starting relatively high at 15.8%, it experienced a decline reaching a low around 10.36%, followed by a recovery to peaks above 16% in mid-periods. However, in more recent quarters, the margin showed a tendency towards stabilization within the 11% to 14% interval, with minor fluctuations but no definitive upward or downward trend. This variability suggests periods of changing profitability, potentially due to shifts in operating costs, pricing, or revenue mixes.
Asset Turnover
The asset turnover ratio displayed a gradual and consistent improvement over time, beginning near 0.3 and increasing steadily to reach approximately 0.38 by the final quarters. This indicates an enhancement in the efficiency of asset utilization to generate revenue. The growth pattern is steady without abrupt changes, reflecting effective asset management strategies and possibly an expansion of sales relative to asset base growth.
Return on Assets (ROA)
The return on assets mirrored a somewhat cyclical trend with an initial decline from 4.7% to about 2.97%, followed by a recovery phase peaking above 5.5%. Subsequent quarters presented moderate oscillations around the 4% to 5% range, with a slight upward tendency towards the end, hitting around 5.22%. This trend suggests fluctuations in profitability relative to the company's assets, influenced by both operational performance and potentially asset base adjustments.

Overall, the data indicate that while profitability margins have experienced some variability, the company has demonstrated improving efficiency in asset utilization and a generally stable, if somewhat oscillating, return on assets. The combination of steady asset turnover growth and moderate profitability margin stabilization points to potential operational improvements and adaptive financial management over the reviewed quarters.


Four-Component Disaggregation of ROA

Medtronic PLC, decomposition of ROA (quarterly data)

Microsoft Excel
ROA = Tax Burden × Interest Burden × EBIT Margin × Asset Turnover
Oct 24, 2025 = × × ×
Jul 25, 2025 = × × ×
Apr 25, 2025 = × × ×
Jan 24, 2025 = × × ×
Oct 25, 2024 = × × ×
Jul 26, 2024 = × × ×
Apr 26, 2024 = × × ×
Jan 26, 2024 = × × ×
Oct 27, 2023 = × × ×
Jul 28, 2023 = × × ×
Apr 28, 2023 = × × ×
Jan 27, 2023 = × × ×
Oct 28, 2022 = × × ×
Jul 29, 2022 = × × ×
Apr 29, 2022 = × × ×
Jan 28, 2022 = × × ×
Oct 29, 2021 = × × ×
Jul 30, 2021 = × × ×
Apr 30, 2021 = × × ×
Jan 29, 2021 = × × ×
Oct 30, 2020 = × × ×
Jul 31, 2020 = × × ×

Based on: 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).


The analysis of the financial ratios over the indicated periods shows several discernible trends related to the company's operational efficiency, profitability, and leverage impact.

Tax Burden
The tax burden ratio exhibits a declining trend from above 1.20 in mid-2020 to a low of around 0.66 in early 2023, followed by a moderate increase stabilizing near 0.83-0.84 towards late 2025. This pattern indicates a reduction in the effective tax rate initially, which could reflect tax optimization or changes in income mix, and a stabilization thereafter.
Interest Burden
Interest burden demonstrates a fluctuating but generally stable pattern. It starts around 0.85, drops to approximately 0.73 in early 2021, then recovers to about 0.90 and remains relatively consistent in the 0.87 to 0.89 range thereafter. This suggests moderate fluctuations in interest expense relative to earnings but overall stability in interest costs impacting profit availability.
EBIT Margin
The EBIT margin shows an upward trajectory from 15.43% in mid-2020 to a peak exceeding 20% in mid-2022. Thereafter, it slightly declines and stabilizes between 17% and 19% in the subsequent periods up to 2025. This indicates improving operating profitability initially, possibly due to operational efficiencies or cost control, followed by normalization at a higher level than the early period.
Asset Turnover
Asset turnover steadily improves from 0.30 to 0.38 over the full period. This continuous improvement suggests increasing efficiency in the use of assets to generate revenue, reflecting better asset management or revenue growth outpacing asset base expansion.
Return on Assets (ROA)
The ROA displays a more volatile trend, declining from 4.7% down to near 3% in early 2021, then recovering and increasing to above 5% by late 2025. This indicates initial profitability pressures followed by strong improvements in asset profitability, likely driven by improved margins and asset utilization.

Overall, the data reflects a company that has experienced improvements in operational efficiency and profitability from 2020 through 2022 with some normalization thereafter. The sustained improvement in asset turnover combined with a higher EBIT margin contributes to an enhanced return on assets, despite fluctuations in tax and interest burdens. The stability in interest burden and a moderate tax burden in recent periods suggest consistent financial management in terms of leverage and tax planning.


Disaggregation of Net Profit Margin

Medtronic PLC, decomposition of net profit margin ratio (quarterly data)

Microsoft Excel
Net Profit Margin = Tax Burden × Interest Burden × EBIT Margin
Oct 24, 2025 = × ×
Jul 25, 2025 = × ×
Apr 25, 2025 = × ×
Jan 24, 2025 = × ×
Oct 25, 2024 = × ×
Jul 26, 2024 = × ×
Apr 26, 2024 = × ×
Jan 26, 2024 = × ×
Oct 27, 2023 = × ×
Jul 28, 2023 = × ×
Apr 28, 2023 = × ×
Jan 27, 2023 = × ×
Oct 28, 2022 = × ×
Jul 29, 2022 = × ×
Apr 29, 2022 = × ×
Jan 28, 2022 = × ×
Oct 29, 2021 = × ×
Jul 30, 2021 = × ×
Apr 30, 2021 = × ×
Jan 29, 2021 = × ×
Oct 30, 2020 = × ×
Jul 31, 2020 = × ×

Based on: 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30), 10-K (reporting date: 2021-04-30), 10-Q (reporting date: 2021-01-29), 10-Q (reporting date: 2020-10-30), 10-Q (reporting date: 2020-07-31).


The analysis of the quarterly financial ratios reveals several notable trends over the examined periods.

Tax Burden
The tax burden ratio exhibited a general downward trend from July 2020 through April 2023, decreasing from above 1.2 to a low around 0.66. Following this period, the ratio stabilized and showed a modest upward trend, rising gradually above 0.8 by late 2025. This indicates a reduction in the effective tax rate initially, followed by stabilization at a relatively lower level compared to the beginning of the period.
Interest Burden
The interest burden ratio experienced fluctuations early in the timeline, starting around 0.85 in mid-2020, dipping to approximately 0.73 by early 2021, then recovering and maintaining a relatively stable level near 0.9 from mid-2021 onward. Slight decreases and increases occurred thereafter, but overall the ratio remained close to 0.87-0.89 towards the later quarters. This suggests relatively consistent interest expenses relative to earnings before interest and taxes, with some improvement in interest management early in the period.
EBIT Margin
The EBIT margin showed an overall increasing trend during the majority of the period under review. The margin rose from about 15.4% in July 2020 to a peak exceeding 20% between mid-2022 and early 2023. Following this peak, the margin experienced slight declines and then stabilized within a range near 17%-19% toward late 2025. This pattern reflects enhanced operating profitability over time, albeit with some moderation after reaching peak levels.
Net Profit Margin
The net profit margin demonstrated more variability compared to EBIT margin but generally followed an upward trajectory from mid-2020 to the mid-2022 timeframe, increasing from under 13% to approximately 16.7%. After this period, a gradual decrease occurred until early 2024, followed by fluctuations around 12%-14% range through to late 2025. The net margin trend indicates variations likely influenced by tax and interest burdens as well as operating performance, with profitability stabilizing at a level somewhat below the earlier peak.

In summary, the data suggest improvements in operating efficiency and cost management over the initial years, reflected in rising EBIT margins and a recovery of interest burden ratios. Profitability metrics indicate a peak period around late 2022 followed by a modest decline and stabilization. The evolving tax burden ratio implies changes in the effective tax rate that may have contributed to fluctuations in net profitability. Overall, the company maintained solid profitability and controlled costs reasonably well across the quarters analyzed.